Litcius/Paper detail

Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy

Junwei Zhu, Jun Su

2021Indian Journal of Microbiology16 citationsDOIOpen Access PDF

Topics & Concepts

TemozolomideBevacizumabMedicineOncologyInternal medicineGliomaDacarbazineGlioblastomaRadiation therapyCancer researchChemotherapyGut microbiota and healthRadiomics and Machine Learning in Medical ImagingFerroptosis and cancer prognosis
Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy | Litcius